TRANSLATE

Welcome to Our Parkinson's Place


I copy news articles pertaining to research, news and information for Parkinson's disease, Dementia, the Brain, Depression and Parkinson's with Dystonia. I also post about Fundraising for Parkinson's disease and events. I try to be up-to-date as possible. I have Parkinson's
diseases as well and thought it would be nice to have a place where
updated news is in one place. That is why I began this blog.
I am not responsible for it's contents, I am just a copier of information searched on the computer. Please understand the copies are just that, copies and at times, I am unable to enlarge the wording or keep it uniformed as I wish. This is for you to read and to always keep an open mind.
Please discuss this with your doctor, should you have any questions, or concerns. Never do anything without talking to your doctor. I do not make any money from this website. I volunteer my time to help all of us to be informed. Please No advertisers, and No Information about Herbal treatments. This is a free site for all.
Thank you.


Thursday, March 13, 2014

Using Telemedicine to Deliver Patient-Centered Care to Patients with Parkinson’s Disease Anywhere.

For 2013-2014, the Davis Phinney Foundation is funding Dr. E. Ray Dorsey
the University of Rochester’s study,Using Telemedicine to Deliver
Patient-Centered Care to Patients with Parkinson’s Disease Anywhere.
Many people with Parkinson’s are not able to receive the medical care they need to 
take better charge of their condition and live well today. Barriers include distance, 
disability, and distribution of doctors. Using simple web-based video conferencing, 
Dr. Dorsey’s previous studies have demonstrated the value of a telemedicine 
approach. Doctors specializing in Parkinson’s care meet with patients over 
the internet, assessing symptoms and discussing patient concerns
during the telemedicine visit. Compared with in-person, clinic visits,
previous studies show that each telemedicine visit saved participants, 
on average, 100 miles of travel and 3 hours of time, and had comparable
 benefits to an in–person doctor’s visit.
Dr. Dorsey’s 2013-2014 study aims to expand this telemedicine program in four states
 (Maryland, Florida, New York, and California), enabling more patients to receive care 
from Parkinson disease specialists, independent of their location, level of disability, and
 ability to pay. The primary purpose is to improve the quality of life for individuals
 (and their caregivers and families) with Parkinson’s disease by measuring the impact
of remote care, demonstrating the national feasibility of conducting remote evaluations,
 and assessing the long-term acceptability to patients in receiving ongoing care
remotely through telemedicine.

Wednesday, March 12, 2014

MAGNETIC RESONANCE IMAGING ACCURATELY DIAGNOSES PARKINSON'S DISEASE

10th March 2014 - New research


Radiology [2014] Feb 26 [Epub ahead of print] (M.Cosottini, D.Frosini, I.Pesaresi, M.Costagli, L.Biagi, R. Ceravolo, U.Bonuccelli, M.Tosetti) Complete abstract

Parkinson's Disease has been diagnosed with almost complete accuracy using a scanning method called Magnetic Resonance Imaging (MRI).
 Magnetic resonance imaging (MRI) is a type of scan that uses strong magnetic fields and radio waves to produce detailed images of the inside of the body. An MRI scanner is a large tube that contains powerful magnets. The patient lays inside the tube during the scan and is moved into the scanner either head or feet first. The MRI scanner is operated by a radiographer who controls the scanner using a computer. For more information go toMagnetic Resonance Imaging

An evaluation was carried out of the substantia nigra (SN) of people who did and who did not have Parkinson's Disease. The substantia nigra (SN) is the area of the brain most affected by Parkinson's Disease. Deviations from the normal appearance of the substantia nigra were described and indicated as abnormal. The abnormal architecture of the substantia nigra allowed a discrimination between people who did and who did not have Parkinson's Disease with a sensitivity and specificity of 100% and 96% respectively. F